Pop Mart's shares dropped more than 4% after it reported first-half revenue of 17.17 billion yuan, up 23.8% year-over-year but below expectations due to declines in Asia Pacific (excluding China) and the Americas. Revenue in China grew 47.3%, but sales fell 9.7% in Asia Pacific ex-China and 16.5% in the Americas. Citi highlighted challenges in overseas markets including inventory and logistics issues, leading to a forecasted 8% revenue decline in 2026 and a lowered price target. Management now sees its initial 20% revenue growth goal for 2026 as difficult amid rising competition and operational hurdles.
Dogecoin (DOGE) surged 10% to around $0.078, driven by a broader memecoin market rally and integration with Paxos, which powers PayPal and Venmo payments. This move coincided with increased trading volume and open interest in DOGE futures, supported ...
The OM token fell 18.5% to a record low of $0.004126 following an emergency shutdown of the MANTRA blockchain due to an unidentified security incident. All network activity, including block production and transactions, was suspended as the team inves...
South Korea's Upbit exchange added four new altcoins—ETHGas (GWEI), Biconomy (BICO), Bubblemaps (BMT), and Nillion (NIL)—with trading pairs in BTC and USDT. ETHGas saw the biggest immediate price jump of about 11%, while the others rose over 7%. Trad...
Tekcapital's portfolio company Guident has signed a 36-month agreement with Coastal Waste & Recycling to deploy its WatchBot autonomous inspection robots and AI software across more than 40 Coastal locations. The system will conduct facility patrols,...
Corcept Therapeutics is rated Strong Buy with price targets of $163 in one year and $222 in two years, driven by rapid revenue and margin growth. The company’s new drug Lifyorli is launching quickly for platinum-resistant ovarian cancer, and Korlym c...
